We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Air Purifier Destroys Airborne Viruses and Bacteria

By HospiMedica International staff writers
Posted on 04 May 2020
A novel air purifier uses photo electrochemical oxidation (PECO) to destroy volatile organic compounds (VOCs), mold, bacteria, viruses and allergens.

The Molekule (San Francisco, CA, USA) Air Pro RX air purifier is a medical grade device that is designed to destroy bacteria and viruses in the air. More...
The system has been optimized for use in operating rooms (ORs), emergency department (ED) waiting rooms, isolation units, and other critical or high-traffic areas in various healthcare facilities that need frontline protection. Via PECO technology, Air Pro RX demonstrates greater than 5-log (99.999%) reduction of virus bioaerosols, keeping patients and healthcare staff better protected in high-risk areas.

The system does not require any installation, and works immediately after start-up. It comes with a pre-filter optimized for large particle capture, and the PECO-Filter, which is optimized to destroy bacteria, viruses, and other airborne contaminants. The Air Pro RX is also easily cleaned, and is compatible with standard wipe-down disinfection protocols used in hospital facilities. Molekule also offers a non-medical grade air purifier, the Air Pro, which is suitable for large-scale, highly trafficked commercial spaces, such as office spaces, grocery stores, schools, sporting facilities, indoor commercial farming, and more.

"As a company rooted in scientific innovation, we are constantly looking at ways to bring the power of PECO technology to those who need it most,” said Jaya Rao, co-founder and co-CEO of Molekule. “We are facing an invisible threat in the air, and it's more important than ever to get our PECO technology into medical facilities where patients are in respiratory distress and healthcare workers are at a high risk of airborne exposure. The launch of Air Pro RX allows us to reach those at their most vulnerable.”

PECO is an innovative technology that utilizes free radicals to break down pollutants at a molecular level, including VOCs, bacteria, mold, viruses, and allergens. By using nanotechnology, PECO is able to destroy pollutants 1,000 times smaller than standard filters must meet to qualify as a high efficiency particulate air (HEPA) filter.

Related Links:
Molekule


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.